Navitas Life Sciences has vast experience and expertise to discuss strategies in well structured webinars that are a must watch. If you missed watching them live, then here is your chances to watch the best webinars in 2022.
1) Risk Mitigation in Gene Therapy Clinical Trials Development
Download our On-demand webinar to listen to our subject matter experts as they explore key themes regarding
- Risk Mitigation in Gene Therapy Clinical Trials
- Gene Therapy in Diabetes
- Opportunities and Challenges in Gene Therapy Clinical Trials
Dr. Narendra Chirmule
CEO
SymphonyTech
Dr. Kirk Hammond
Professor of Medicine,
UC San Diego and Founder
Renova Therapeutics
Dr. Atul Gupta
Vice President-Medical & Scientific Affairs
Navitas Life Sciences
2) Don’t Treat Your Registry like your Clinical Trials
Watch this webinar to listen to our subject matter experts as they explore key themes regarding
- How Registries are different from Clinical Trials?
- How to effectively support the development of a Registry?
- Which systems and strategies are necessary to develop a successful Registry
Yun Lu
Chief Science & Innovation Officer
Navitas Clinical Research
Sarah Lawrence
Sr. Clinical Project Manager
Navitas Clinical Research
3) Digital Registry Platforms - Considerations for EHR/EDC Integration
In this webinar, our subject matter experts explores key themes regarding
- What goes into Registry platform planning
- How EHR - EDC integration can accelerate your registry study
- How to obtain Optimized Digital Solutions through the data coordinating center
Yun Lu
Chief Science & Innovation Officer
Navitas Clinical Research
Cal Collins
Chief Executive Officer
OpenClinica
Andra Matthews
Senior Clinical Project Manager
Navitas Clinical Research
Navitas Clinical Research (a part of Navitas Life Sciences) has over 30 years of expertise in managing early through late phase clinical trials and registries & other observational studies. Our clients include US Federal Government institutes and non-profits.
4) Innovation and Optimization in Early Phase Oncology Studies: Opportunity for speed, success and savings
Listen to our On-demand webinar as our subject matter experts explores key themes regarding
- How applying innovative designs in early phase oncology trials can accelerate timelines and reduce costs
- How to focus development on the most promising agents at the right doses in the right indications for the right patients
- Simple strategies on Dose Escalation: A legacy of statistical innovation
- Expert insights on Novel endpoints to sail through dose expansion and proof of concept
Dr. Atul Gupta
Vice President-Medical & Scientific Affairs
Navitas Life Sciences
Venkatesan Balu
Associate Director – Global Data Sciences
Navitas Life Sciences
GAIN FROM NAVITAS LIFE SCIENCES’ VAST EXPERIENCE
Navitas Life Sciences supports small to large pharma, biotech and devices companies, generics manufacturers, and U.S federal agencies like the Centers for Disease Control and Prevention (CDC) and The U.S. Department of Defense (DoD), with 30+ years of rich experience across 550+ phase I-IV clinical trials, 20+ therapeutic areas expertise, and delivering platform-driven full-service Clinical, Regulatory, Safety solutions and Clinical Registry services.
To learn more about our services and solutions, reach out to us at